Despite the limitations of these animal model studies, however, the findings reported in the manuscript describe a novel pathogenic mechanism in NP–C and reveal a potential approach for the therapy via the VEGF/SphK pathway. This evidence concerns the gene VEGFA and nasopharyngeal carcinoma.